Ubs Group Ag Night Hawk Biosciences, Inc. Transaction History

Ubs Group Ag

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$0.15 - $0.45 $24,042 - $72,126	160,280 Added 4848.15%	163,586 $26,000
Q4 2023 Feb 09, 2024	BUY	$0.26 - $0.51 $262 - $515	1,010 Added 43.99%	3,306 $1,000
Q3 2023 Nov 09, 2023	BUY	$0.5 - $0.72 $1,112 - $1,602	2,225 Added 3133.8%	2,296 $1,000
Q2 2023 Aug 11, 2023	SELL	$0.62 - $0.87 $1,516 - $2,128	-2,446 Reduced 97.18%	71 $0
Q1 2023 May 12, 2023	SELL	$0.83 - $1.24 $6,896 - $10,303	-8,309 Reduced 76.75%	2,517 $2,000
Q4 2022 Feb 08, 2023	BUY	$0.77 - $1.62 $1,552 - $3,265	2,016 Added 22.88%	10,826 $8,000
Q3 2022 Nov 10, 2022	BUY	$1.79 - $2.96 $15,642 - $25,867	8,739 Added 12308.45%	8,810 $15,000
Q2 2022 Aug 10, 2022	SELL	$1.65 - $3.13 $6,776 - $12,854	-4,107 Reduced 98.3%	71 $0
Q1 2022 May 16, 2022	BUY	$2.1 - $3.54 $1,545 - $2,605	736 Added 21.38%	4,178 $13,000
Q4 2021 Feb 14, 2022	BUY	$3.04 - $6.01 $6,420 - $12,693	2,112 Added 158.8%	3,442 $10,000
Q3 2021 Nov 15, 2021	BUY	$5.9 - $7.44 $7,428 - $9,366	1,259 Added 1773.24%	1,330 $7,000
Q1 2021 May 12, 2021	SELL	$5.67 - $12.54 $83,689 - $185,090	-14,760 Reduced 99.52%	71 $1,000
Q4 2020 Feb 11, 2021	BUY	$5.28 - $9.59 $78,307 - $142,229	14,831 New	14,831 $80,000

58.7K

Ticker NHWK
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,661,500
Market Cap $4.11M
Description
NightHawk Biosciences, Inc., an integrated biopharmaceutical company, engages in the development of immune therapies and vaccines. The company's therapies are used to modulate the immune system against various diseases, including cancer and infectious diseases. Its gp96 platform, including ImPACT, an allogenic cell-based, T-cell-stimulating plat...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.